Comparative Pharmacokinetics/Pharmacodynamic Modeling on Three Brands of 10% Enrofloxacin Oral Formulations in Broiler Chickens
DOI:
https://doi.org/10.3923/ijps.2010.273.277Keywords:
Brands, chickens, enrofloxacin, pharmacodynamic, pharmacokinetic, resistanceAbstract
A comparative plasma pharmacokinetics/Pharmacodynamic modeling of enrofloxacin following administration of three brands of 10% enrofloxacin was studied in healthy broiler chickens using a randomized and parallel design. Pre-treatment and post-treatment samples were obtained from brachial or right jugular veins after having administered 20 mg/kg b.w of enrofloxacin at 0, 0.5, 1, 2, 3, 4, 6, 8, 10, 12 and 24 h. Plasma samples were analyzed for enrofloxacin concentration by a simple agar disk diffusion microbiological assay. Selected pharmacokinetics parameters were calculated using a non-compartmental model. There was a significant difference in the plasma concentration-time and pharmacokinetics profiles (p<0.05) of the three brands. But the plasma concentrations of enrofloxacin exceeded the MIC90 for most pathogenic bacterial organisms in poultry in all the groups. The PK/PD integration (Cmax/MIC90) values, 16.67, 15.17 and 10.5 h were obtained in animals administered conflox®-vet, kenflox® and pulmotryl® formulations respectively. This correlates with high efficacy and reduced chances for the development of resistant pathogenic bacterial organisms following oral administration of these brands of enrofloxacin oral formulations in broiler chickens.
References
Anadon, A., M.R. Martinez-Larranaga, M.J. Diaz, P. Bringas and M.A. Martinez et al., 1995. Pharmacokinetics and residues of enrofloxacin in chickens. Am. J. Vet. Res., 56: 501-506.
Zuluaga, A.F., M. Agudelo, C.A. Rodriguez and O. Vesga, 2009. Application of microbiological assay to determine pharmaceutical equivalence of generic intravenous antibiotics. BMC Clin. Pharmacol., 9: 1-1.
Baggot, J.D., 2001. The Physiological Basis of Veterinary Clinical Pharmacology. 1st Edn., Blackwell, London.
Bryant, M.C., 1981. The Assay of Antibiotics in Body Fluids. In: Laboratory Control of Antibacterial Chemotherapy, Bryant, M.C. (Ed.). 1st Edn., John Wright, London, ISBN: 0723605947, pp: 102-123.
Craig, W.A., 1993. Pharmacodynamics of antimicrobial gents as a basis for determination of dosage regimens. Eur. J. Clin. Microbiol. Infec. Dis., 12: S6-S8.
Dowling, P.M., R.C. Wilson, J.W. Tyler and S.H. Duran, 1995. Pharmacokinetics of ciprofloxacin in ponies. J. Vet. Pharmacol. Ther., 18: 7-12.
Abu-Basha, E.A., S.M. Gharaibeh, A.M. Abudabos, A.F. Shunnaq and A.M. Al-Majali, 2008. Pharmacokinetics and bioequivalence of two norfloxacin oral dosage forms (Vapcotril-10%® and Mycomas 10%®) in healthy broiler chickens. Int. J. Poult. Sci., 7: 289-293.
Gilbadi, M. and P. Perrier, 1982. Pharmacokinetics. 2nd Edn., Marcel Dekker Inc., New York.
Haritova, A., H. Djeneva, L. Lashev, P. Sotirova, B. Gyurov and M. Stefanova, 2004. Pharmacokinetics and PK/PD modeling of enrofloxacin in Meleagris gallopavo and gallus domesticus. Bulg. J. Vet. Med., 7: 139-148.
Kwasi, B., W.D. Black and M.E. Scott, 1999. Pharmacokinetics of enrofloxacin given by oral, intravenous and intramuscular routes in broiler chickens. Can. J. Vet. Res., 63: 193-200.
Lakshmi, K., 2006. Modeling success in PK/PD testing. Drug Discov. Dev.
Marie, G., 2007. PK/PD Data analysis 1-basic concept. The Medical Products Agency (MPA).
Meinen, J.B., J.T. McClure and E. Rosin, 1995. Pharmacokinetic of enrofloxacin in clinically normal dogs and mice drug pharmacodynamics in neutropenic mice with E. coli and Staphylococcal infections. Am. J. Vet. Res., 56: 1219-1224.
Mouton, J.W. and P.M. Tulkens, 2005. PK/PD modeling: Clinical implication. Proceeding of the ICAACBISAP PK/PD Workshop, April 2, Belgium, Netherlands, pp: 1-57.
Posyniak, A., J. Zmudzki, J. Niedzielska and B. Biernacki, 2001. Bioequivalence study of two formulations of enrofloxacin following oral administration in chickens. Bul. Vet. Res. Inst. Pulawy, 45: 353-358.
Radandt, K.M., M.C. Randall and M.N. Dudley, 1992. Interactions of fluoroquinolones with other drugs: Mechanisms, variability, clinical significance and management. Clin. Infect. Dis., 14: 272-284.
Reiko, S., T. Yusuke, K. Mitsuo, A. Naoki and S. Kihachiro, 2006. Pharmacokinetics-Pharmaco-dynamics relationship of arbekacin for treatment of patients infected with methicillin-resistant Staphylococcus aureus. J. Antimicrob. Agent Chemother., 50: 3754-3762.
Sanjib, I., C.B. Chandana, M. Pritam and B. Mohan, 2005. Pharmacokinetics studies of enrofloxacin in Yak after intramuscular administration. Ir. J. Pharmacol. Therap., 4: 91-94.
Sumano, L.H. and O.L. Gutierrez, 2000. Problematica del uso de la enrofloxacin en la aviculture en Mexico. Vet. Mex., 2: 137-145.
Sumano, L.H. and O.L. Gutierrez, 2001. Strategic administration of enrofloxacin in poultry to achieve higher serum concentrations. Proceedings of the 15th Western Poultry Disease Conference. March 24-26 University of California, Davis, pp: 45-48.
Downloads
Published
Issue
Section
License
Copyright (c) 2010 Asian Network for Scientific Information
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
